दिमाग का ट्यूमर (medulloblastoma)
Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
कहाँ जाना है
इस trial के लिए 1 hospital भारत में मरीज़ ले रहा है।
रजिस्ट्री समरी (तकनीकी)
Radiation constitutes an integral component in the management of primary brain tumors in pediatric and young adults like medulloblastoma, ependymoma, low-grade glioma, pituitary tumors, etc. A decline in neurocognitive outcomes is a multifactorial effect occurring from the primary disease as well as associated with treatments, including radiation. Since many of these tumors are highly curable, it is crucial to reduce long-term side effects, including memory loss, to improve the quality of life in these patients, leading to better rehabilitation. Radiation-induced neurocognitive deterioration i…
प्रायोजक: Tata Memorial Centre
ClinicalTrials.gov पर NCT06779487
रजिस्ट्री में आखिरी अपडेट 11 Apr 2025 · हमने 20 Oct 2026 को पढ़ा